DK2300609T3 - Hidtil ukendt flagellinbaserede immunadjuvansforbindelser samt anvendelse deraf - Google Patents

Hidtil ukendt flagellinbaserede immunadjuvansforbindelser samt anvendelse deraf

Info

Publication number
DK2300609T3
DK2300609T3 DK09769254.5T DK09769254T DK2300609T3 DK 2300609 T3 DK2300609 T3 DK 2300609T3 DK 09769254 T DK09769254 T DK 09769254T DK 2300609 T3 DK2300609 T3 DK 2300609T3
Authority
DK
Denmark
Prior art keywords
newly known
immunoadjuvant compounds
known flagellin
flagellin
immunoadjuvant
Prior art date
Application number
DK09769254.5T
Other languages
English (en)
Inventor
Jean-Claude Sirard
Original Assignee
Inst Nat Sante Rech Med
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med, Pasteur Institut filed Critical Inst Nat Sante Rech Med
Application granted granted Critical
Publication of DK2300609T3 publication Critical patent/DK2300609T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/255—Salmonella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK09769254.5T 2008-06-25 2009-06-23 Hidtil ukendt flagellinbaserede immunadjuvansforbindelser samt anvendelse deraf DK2300609T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08305327 2008-06-25
PCT/EP2009/057836 WO2009156405A1 (en) 2008-06-25 2009-06-23 Novel immunoadjuvant flagellin-based compounds and use thereof

Publications (1)

Publication Number Publication Date
DK2300609T3 true DK2300609T3 (da) 2014-02-10

Family

ID=39967832

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09769254.5T DK2300609T3 (da) 2008-06-25 2009-06-23 Hidtil ukendt flagellinbaserede immunadjuvansforbindelser samt anvendelse deraf

Country Status (20)

Country Link
US (2) US9527891B2 (da)
EP (2) EP2300609B1 (da)
JP (2) JP5756750B2 (da)
KR (1) KR101684447B1 (da)
CN (2) CN103641898B (da)
AU (1) AU2009264257B2 (da)
BR (1) BRPI0914691A2 (da)
CA (1) CA2728038A1 (da)
CY (1) CY1114820T1 (da)
DK (1) DK2300609T3 (da)
EA (1) EA019138B1 (da)
ES (1) ES2445798T3 (da)
HR (1) HRP20140109T1 (da)
IL (1) IL209781A (da)
MX (1) MX2010014575A (da)
PL (1) PL2300609T3 (da)
PT (1) PT2300609E (da)
RS (1) RS53158B (da)
SI (1) SI2300609T1 (da)
WO (1) WO2009156405A1 (da)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2728038A1 (en) * 2008-06-25 2009-12-30 Inserm (Institut National De La Sante Et De La Recherche Medicale) Novel immunoadjuvant flagellin-based compounds and use thereof
US9701723B2 (en) 2010-02-18 2017-07-11 Icahn School Of Medicine At Mount Sinai Vaccines for use in the prophylaxis and treatment of influenza virus disease
MX2012011300A (es) 2010-03-30 2012-11-29 Sinai School Medicine Vacunas del virus de influenza y usos de las mismas.
GB201009273D0 (en) 2010-06-03 2010-07-21 Glaxosmithkline Biolog Sa Novel vaccine
KR101768118B1 (ko) * 2010-06-25 2017-08-14 인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) 기도 감염의 치료를 위한 방법 및 약학 조성물
HK1200102A1 (en) 2011-09-20 2015-07-31 西奈山医学院 Influenza virus vaccines and uses thereof
EP2744549A1 (en) * 2011-10-04 2014-06-25 Koninklijke Philips N.V. Forehead gas supply assembly for a patient interface system
GB201119999D0 (en) * 2011-11-20 2012-01-04 Glaxosmithkline Biolog Sa Vaccine
GB201120000D0 (en) * 2011-11-20 2012-01-04 Glaxosmithkline Biolog Sa Vaccine
US9296792B2 (en) * 2012-05-23 2016-03-29 The Board Of Trustees Of The Leland Stanford Junior University Ordered flagellin array as an immunostimulant
RU2510281C2 (ru) * 2012-06-22 2014-03-27 Общество с ограниченной ответственностью "Эпитоп" (ООО "Эпитоп") ВАКЦИНА ПРОТИВ ПНЕВМОНИИ, ВЫЗЫВАЕМОЙ Streptococcus pneumoniae, НА ОСНОВЕ ГИБРИДНОГО БЕЛКА
NZ627796A (en) 2012-12-18 2017-07-28 Icahn School Med Mount Sinai Influenza virus vaccines and uses thereof
CN103055311B (zh) * 2012-12-28 2014-05-21 中山大学 一种传染性喉气管炎粘膜疫苗及其制备方法和应用
US9908930B2 (en) 2013-03-14 2018-03-06 Icahn School Of Medicine At Mount Sinai Antibodies against influenza virus hemagglutinin and uses thereof
US9919029B2 (en) * 2013-07-26 2018-03-20 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods and pharmaceutical compositions for the treatment of bacterial infections
WO2015130584A2 (en) 2014-02-25 2015-09-03 Merck Sharp & Dohme Corp. Lipid nanoparticle vaccine adjuvants and antigen delivery systems
JP2017537650A (ja) 2014-10-09 2017-12-21 ライポテック・ピーティーワイ・リミテッド キメラタンパク質
JP6912379B2 (ja) * 2014-12-23 2021-08-04 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル インフルエンザ後の細菌重感染を処置するための方法及び医薬組成物
EP3247389A4 (en) 2015-01-23 2019-10-30 Icahn School of Medicine at Mount Sinai INFLUENZAVIRUSSCHUTZIMPFPLÄNE
CN104610456A (zh) * 2015-01-27 2015-05-13 扬州大学 一种 h7n9 亚型禽流感亚单位疫苗的制备方法及应用
RU2015109715A (ru) * 2015-03-19 2015-08-20 Общество С Ограниченной Ответственностью "Рд-Биотех" (Ооо "Рд-Биотех") ПРОТИВОТУБЕРКУЛЕЗНАЯ ВАКЦИНА НА ОСНОВЕ РЕКОМБИНАНТНЫХ БЕЛКОВ Ag85B, TB10.4, FliC
MX2018015755A (es) 2016-06-15 2019-08-29 Icahn School Med Mount Sinai Proteinas de hemaglutinina de virus de influenza y usos de las mismas.
CN106362144B (zh) * 2016-10-31 2021-02-09 武汉三利生物技术有限公司 呼吸道合胞病毒疫苗
RU2647831C1 (ru) * 2017-03-15 2018-03-19 Федеральное государственное унитарное предприятие "Государственный научно-исследовательский институт особо чистых биопрепаратов" Федерального медико-биологического агентства Вакцина против туберкулеза
CA3058652A1 (en) 2017-04-07 2018-10-11 Icahn School Of Medicine At Mount Sinai Anti-influenza b virus neuraminidase antibodies and uses thereof
EP3581201A1 (en) 2018-06-15 2019-12-18 GlaxoSmithKline Biologicals S.A. Escherichia coli o157:h7 proteins and uses thereof
US12364746B2 (en) 2018-06-21 2025-07-22 Icahn School Of Medicine At Mount Sinai Mosaic influenza virus hemagglutinin polypeptides and uses thereof
WO2020063370A2 (zh) 2018-09-27 2020-04-02 武汉博沃生物科技有限公司 免疫组合物及其制备方法与应用
WO2020140973A1 (en) * 2019-01-03 2020-07-09 Nanjing Legend Biotech Co., Ltd. Modified immune cells expressing flagellin polypeptide
CA3137160A1 (en) 2019-04-24 2020-10-29 Icahn School Of Medicine At Mount Sinai Anti-influenza b virus neuraminidase antibodies and uses thereof
FR3114970B1 (fr) 2020-10-08 2023-06-30 Univ Tours Combinaison d’anticorps inhalés avec des agents immunomodulateurs pour le traitement ou la prévention d’inféctions respiratoires
MX2023006320A (es) 2020-12-02 2023-06-14 Glaxosmithkline Biologicals Sa Cadena donante complementada fimh.
US20220226465A1 (en) 2021-01-18 2022-07-21 ConserV Bioscience Coronavirus Immunogenic Compositions, Methods and Uses Thereof
KR20240027752A (ko) 2021-06-30 2024-03-04 인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) 플라겔린의 폐 전달을 위한 에어로졸 조성물
CN114292314B (zh) * 2022-01-05 2022-08-09 武汉科前生物股份有限公司 一种鞭毛素突变体及其在制备非洲猪瘟抗原融合蛋白中的应用
WO2025172452A1 (en) 2024-02-14 2025-08-21 Institut National de la Santé et de la Recherche Médicale Combination for treating bacterial infection due to pseudomonas aeruginosa antibiotic-resistant strain

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004022092A2 (en) * 2002-09-03 2004-03-18 Fondation Eurovacc Flagellin peptides as adjuvants for vaccines
CA2555253A1 (en) * 2004-02-06 2005-08-25 Yale University Compositions of pamps and listeria monocytogenes and methods of use
WO2005107381A2 (en) * 2004-05-07 2005-11-17 Hans-Gustaf Ljunggren Use of flagellin as an adjuvant for vaccine
JP5094407B2 (ja) * 2004-12-16 2012-12-12 ウェイク・フォレスト・ユニヴァーシティ・ヘルス・サイエンシズ Ｙｅｒｓｉｎｉａｐｅｓｔｉｓの免疫療法におけるフラジェリンの使用
CA2594612A1 (en) * 2005-01-19 2006-07-27 Vaxinnate Corporation Compositions comprising pathogen-associated molecular patterns and antigens and their use to stimulate an immune response
AU2009236585B2 (en) 2008-04-18 2013-03-07 Vaxinnate Corporation Deletion mutants of flagellin and methods of use
CA2728038A1 (en) * 2008-06-25 2009-12-30 Inserm (Institut National De La Sante Et De La Recherche Medicale) Novel immunoadjuvant flagellin-based compounds and use thereof

Also Published As

Publication number Publication date
PT2300609E (pt) 2014-02-17
EP2695941B1 (en) 2015-07-29
CN103641898A (zh) 2014-03-19
EA019138B1 (ru) 2014-01-30
EA201001820A1 (ru) 2011-08-30
EP2300609B1 (en) 2013-11-20
HRP20140109T1 (hr) 2014-03-14
KR20110041479A (ko) 2011-04-21
KR101684447B1 (ko) 2016-12-08
JP5756750B2 (ja) 2015-07-29
PL2300609T3 (pl) 2014-05-30
WO2009156405A8 (en) 2010-03-25
JP6041851B2 (ja) 2016-12-14
US20110110962A1 (en) 2011-05-12
CY1114820T1 (el) 2016-12-14
IL209781A (en) 2013-11-28
US20170021015A1 (en) 2017-01-26
JP2011525371A (ja) 2011-09-22
BRPI0914691A2 (pt) 2015-10-20
WO2009156405A9 (en) 2010-08-19
CN102203252A (zh) 2011-09-28
SI2300609T1 (sl) 2014-04-30
CN103641898B (zh) 2018-04-17
IL209781A0 (en) 2011-02-28
JP2015109837A (ja) 2015-06-18
EP2300609A1 (en) 2011-03-30
CA2728038A1 (en) 2009-12-30
AU2009264257A1 (en) 2009-12-30
US9527891B2 (en) 2016-12-27
AU2009264257B2 (en) 2013-11-07
MX2010014575A (es) 2011-06-17
ES2445798T3 (es) 2014-03-05
WO2009156405A1 (en) 2009-12-30
EP2695941A3 (en) 2014-03-05
EP2695941A2 (en) 2014-02-12
US9956284B2 (en) 2018-05-01
CN102203252B (zh) 2016-08-03
RS53158B (sr) 2014-06-30

Similar Documents

Publication Publication Date Title
HRP20180718T1 (hr) Oligopeptidni spojevi i njihova upotreba
PT3812360T (pt) Compostos de monoclorotrifluoropropeno e composições e métodos utilizando os mesmos
PL2452709T3 (pl) Kaniula
BRPI0815588A2 (pt) Compostos de poliorganossiloxano-poliuréia e/ou de poliorganossilo-xano-poliuretano
BRPI0907231A2 (pt) pirrolpirimidinas e pirrolpiridinas
FIC20240018I1 (fi) Vamoroloni
DK2138716T4 (da) Vingeindsats
BRPI0907376A2 (pt) Fotobiorretador
BRPI0914649A2 (pt) Piprazolo-quinazolinas
DK2132326T3 (da) Fremgangsmåder
DE602008003521D1 (de) Sitzrücklehnungsmechanismus
DK2114993T3 (da) Vaccine
BRPI0914057A2 (pt) edificação alta
DE602008003970D1 (de) Strahlstromkalibriersystem
DK2155273T3 (da) Lugtregulerende genstand
BRPI0907522A2 (pt) biarlamidas
DK3150178T3 (da) Stimuleringsapparat
DE112009000183A5 (de) Sicherheitsvorreiber
BRPI0909634A2 (pt) 2-aminoquinolinas
DE112009001946A5 (de) Mobelauszugsführung
BRPI0909637A2 (pt) 2-aminoquinolinas
AT507449A3 (de) Dämmstoffbefestiger
NO20083166L (no) Fortoyningsarrangement
HRP20160578T1 (hr) Supstituirani furankarboksamidi i njihova upotreba
DE102008019532B8 (de) Ölvormischbrenner